Preview

Medical alphabet

Advanced search

Phenotypic differentiation of patients with chronic heart failure

https://doi.org/10.33667/2078-5631-2020-36-28-33

Abstract

Objective. According to the results of a complex analysis of gender-anamnestic, clinical, biochemical and instrumental parameters using the cluster analysis method to identify phenotypes of chronic heart failure (CHF) in the examined patients.

Materials and methods. It was examined 345 patients with CHF with different left ventricular ejection fraction and 60 somatically healthy volunteers. For the study, groups of indicators were formed that most widely characterize the pathogenesis of CHF: gender-anamnestic and clinical, instrumental (echocardiographic study, study of the functional state of the vascular endothelium and skin microcirculation, calculation of the volume fraction of interstitial collagen), biochemical parameters of the functional state of the vascular endothelium, collagen balance, inflammation and oxidative stress.

Results. After the cluster analysis by the methods of hierarchical classification and k-means, we identified 4 clusters/phenotypes of CHF: fibrous-rigid, fibrous-inflammatory, inflammatory-destructive and dilatation-maladaptive. According to the results of the analysis of variance were identified 27 of the 48 indicators in which the level of statistical significance of intergroup differences (for the Fisher test) was less than 0.05, that is, indicators that make the greatest contribution to the division of patients with CHF into phenotypic groups.

Conclusion. Our analysis with the release of phenotypes indicates that patients with CHF with different phenotypes have clinical and pathogenetic features. The data obtained in the future can be used to determine the prognosis of the disease and the choice of tactics for the management and treatment of patients with CHF depending on the phenotype.

About the Authors

L. P. Voronina
Astrakhan State Medical University
Russian Federation
Astrakhan


O. S. Polunina
Astrakhan State Medical University
Russian Federation
Astrakhan


O. A. Bashkina
Astrakhan State Medical University
Russian Federation
Astrakhan


E. A. Polunina
Astrakhan State Medical University
Russian Federation
Astrakhan


T. V. Prokofieva
Astrakhan State Medical University
Russian Federation
Astrakhan


References

1. Мареев Ю. В., Мареев В.Ю. Характеристика и лечение пациентов с ХСН, госпитализированных в стационар. Кардиология. 2017; 57(S4): 19–30. DOI: 10.18087/cardio.2433.

2. Канорский С. Г., Трегубов В. Г., Покровский В.М. Альтернативная терапия ивабрадином у пациентов с хронической сердечной недостаточностью III функционального класса. Кардиология. 2011; 51 (8): 39.

3. Лясникова Е.А., Улитин А.М., Тишкова В.М. Генетические детерминанты, ассоциированные с развитием и прогнозом постинфарктного ремоделирования и хронической сердечной недостаточности. Трансляционная медицина. 2018; 5 (1): 15–24.

4. Стройкова Т. Р., Башкина О. А., Мизерницкий Ю. Л. Клинико-анамнестическая характеристика и возрастная динамика фенотипов бронхиальной астмы у детей. Астраханский медицинский журнал. 2016; 11 (3): 83–87.

5. Efeovbokhan N., Bhattacharya S.K., Ahokas R.A., Sun Y., Guntaka R.V., Gerling I.C., Weber K. T. Zinc and the prooxidant heart failure phenotype. J Cardiovasc Pharmacol. 2014; 64 (4): 393–400. DOI: 10.1097/FJC.0000000000000125.

6. Березин А.Е., Кремзер А.А., Самура Т.А. Прогностическое значение различных фенотипов циркулирующих эндотелиальных микрочастиц у пациентов с хронической сердечной недостаточностью: результаты проспективного исследования. Серце і судини. 2015; 1: С. 22–30.

7. Мареев В. Ю., Фомин И. В., Агеев Ф. Т., Артюнов Г. П., Беграмбекова Ю. Л., Беленков Ю. Н. и др. Хроническая сердечная недостаточность (ХСН). Журнал «Сердечная недостаточность». 2017; Т. 18 (1): 3–40. DOI: 10.18087/rhfj.2017.1.2346.

8. Liskova V., Stadnikov A.A., Salikova S.P. Gender particulars of morphological phenotypes of the right atrial appendage myocardium in patients with chronic heart failure who underwent an open-heart surgery. Almanac of Clinical Medicine. 2018; 46 (4): 355–366. DOI: 10.18786/2072–0505–2018–46–4–355–366.

9. Арутюнов А. Г., Драгунов Д. О., Арутюнов Г.П., Рылова А. К., Соколова А. В., Рылова Н. В. Прогностически значимые клинические фенотипы больных с декомпенсацией кровообращения в РФ. Журнал Сердечная Недостаточность. 2015; 16 (5): 270–278. DOI: 10.18087/rhfj.2015.5.2135.

10. Potabashniy V. A. The phenotypes of chronic heart failure in patients with ischemic heart disease combined with chronic obstructive pulmonary disease. Medicni perspektivi. 2018; 23 (3): 161–171. DOI: https://doi.org/10.26641/2307–0404.2018.3(part1).142364.

11. Samson R., Jaiswal A., Ennezat P. V., Cassidy M., Le Jemtel T.H. Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc. 2016; 5 (1): pii: e002477. DOI: 10.1161/JAHA.115.002477.

12. Kao D. P., Lewsey J. D., Anand I. S., Massie B. M., Zile M.R., Carson P.E., McKelvie R.S., Komajda M., McMurray J.J., Lindenfeld J. Characterization ofsubgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response. Eur J Heart Fail. 2015; 17 (9): 925–935. DOI: 10.1002/ejhf.327.

13. D’Elia E., Vaduganathan M., Gori M., Gavazzi A., Butler J., Senni M. Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use. Eur J Heart Fail. 2015; 17 (12): 1231–9. DOI: 10.1002/ejhf.430.


Review

For citations:


Voronina L.P., Polunina O.S., Bashkina O.A., Polunina E.A., Prokofieva T.V. Phenotypic differentiation of patients with chronic heart failure. Medical alphabet. 2020;(36):28-33. (In Russ.) https://doi.org/10.33667/2078-5631-2020-36-28-33

Views: 1116


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2078-5631 (Print)
ISSN 2949-2807 (Online)